JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B1449 Mefenamic Acid

Summary: Anti-inflammatory agent

insoluble in H2O; ≥12.06 mg/mL
B1395 Sulfacetamide Sodium

Summary: Sulfonamide antibiotic

≥10.65 mg/mL
B1593 Irsogladine

Summary: PDE4 inhibitor

insoluble in H2O; insoluble in EtOH; ≥12.80 mg/mL
A8219 Gefitinib (ZD1839)
16 Citation

Target: EGFR

Summary: Selective EGFR inhibitor

≥22.34 mg/mL
A8236 Regorafenib
4 Citation

Target: Raf|VEGFR|PDGFR|c-Kit|RET

Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1

≥25.04 mg/mL
A8246 BEZ235 (NVP-BEZ235)
2 Citation

Summary: PI3K/mTOR inhibitor,ATP-competitve

insoluble in DMSO; insoluble in EtOH; insoluble in H2O
B2232 Aripiprazole

Target: 5-HT1 Receptors

Summary: 5-HT receptor partial agonist

≥22.4 mg/mL
B1267 Refametinib

Target: MEK

Summary: MEK 1/ MEK 2 inhibitor

insoluble in H2O; ≥151.8 mg/mL
B1419 Manidipine 2HCl

Summary: Calcium channel blocker

insoluble in H2O; ≥69 mg/mL
B2225 Stavudine (d4T)

Summary: Reverse transcriptase inhibitor

≥51.3 mg/mL